Premium
IC‐P‐024: A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer's disease mouse model
Author(s) -
Snir Jonatan A.,
Suchy Mojmir,
Bindseil Geron A.,
Chronik Blaine A.,
Hudson Robert H.E.,
Pasternak Stephen H.,
Bartha Robert
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.044
Subject(s) - in vivo , cathepsin d , ex vivo , positron emission tomography , chemistry , genetically modified mouse , in vitro , preclinical imaging , microbiology and biotechnology , transgene , medicine , nuclear medicine , biochemistry , biology , enzyme , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom